Tecovirimat (TPOXX) is the first FDA approved drug treatment of smallpox. In 1980, WHO declared that smallpox was eradicated; however, tecovirimat was developed as a counter to the possible use of smallpox as a bio-weapon. It is the first product awarded a Material Threat Medical Countermeasure priority review voucher by the FDA.
- Keep Your Genes On: How to Set Patients’ Expectations of PGx Testing
- FDA Approves a New Version of OTC Inhaler Primatene Mist
- New Physical Activity Guidelines for Americans: “Move more, and sit less”
- FDA Announces an Emergency Use Authorization for “Fingerstick” Ebola Test that Uses a Portable Battery Reader
- French Study finds Association with Organic Food Consumption and Reduced Risk of Cancer